Abstract
BACKGROUND: Breast cancer (BCa)-related mortality still remains the second leading cause of cancer-related deaths worldwide. Patients with BCa have increasingly shown resistance and high toxicity to current chemotherapeutic drugs for which identification of novel targeted therapies are required.
METHODS: To determine the effect of PDBD on BCa cells, estrogen-receptor positive (ER+)-MCF-7 and estrogen-receptor negative (ER-)-MDA 231 cells were treated with PDBD and the cell viability, apoptotic, cell cycle, Western blot and Promoter assays were performed.
RESULTS: PDBD inhibits cell viability of ER+ and ER- BCa cells by inducing apoptosis without causing significant toxicity in normal breast epithelial cells. While dissecting the mechanism of action of PDBD on BCa, we found that PDBD inhibits Akt signaling and its downstream targets such as NF-kappaB activation, IAP proteins and Bcl-2 expression. On the other hand, activation of JNK/p38 MAPK-mediated pro-apoptotic signaling was observed in both ER+ and ER- BCa cells.
CONCLUSION: These findings suggest that PDBD may have wide therapeutic application in the treatment of BCa.
Document Type
Article
Publication Date
1-30-2009
Digital Object Identifier (DOI)
http://dx.doi.org/10.1186/1471-2407-9-41
Repository Citation
Koduru, Srinivas; Sowmyalakshmi, Srinivasan; Kumar, Raj; Gomathinayagam, Rohini; Rohr, Jürgen; and Damodaran, Chendil, "Identification of a potent herbal molecule for the treatment of breast cancer" (2009). Pharmaceutical Sciences Faculty Publications. 13.
https://uknowledge.uky.edu/ps_facpub/13
Notes/Citation Information
Published in BMC Cancer, v. 9, 41.
© 2009 Koduru et al; licensee BioMed Central Ltd.
This is an Open Access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.